Related Experiment Video
Updated: Oct 4, 2025

08:30
RNAi Interference by dsRNA Injection into Drosophila Embryos
Published on: April 11, 2011
16.3K
DROSHA but not DICER is required for human haematopoietic stem cell function.
Karen Gu1,2, Carina Walpole3, Shayarana Gooneratne1
1St Vincent's Institute of Medical Research Fitzroy VIC 3065 Australia.
Clinical & Translational Immunology
|February 2, 2022
Summary
The enzyme DROSHA safeguards human hematopoietic stem cell (HSC) pluripotency through a miRNA-independent pathway. While DROSHA cleaves MYL9 mRNA, this alone is not critical for human HSC function, suggesting other targets are involved.
Area of Science:
- Molecular Biology
- Stem Cell Biology
- Gene Regulation
Background:
- DROSHA and DICER are key in microRNA (miRNA) biogenesis.
- DROSHA also cleaves messenger RNAs (mRNAs) independently of miRNAs, crucial for murine hematopoietic stem cell (HSC) pluripotency.
- This involves cleaving specific mRNAs like Myl9 and Todr1 in mice.
Purpose of the Study:
- To investigate if DROSHA's miRNA-independent mRNA cleavage function is conserved in human HSCs.
- To determine the role of DROSHA in maintaining human HSC pluripotency and function.
Main Methods:
- Short hairpin RNAs were used to knock down DROSHA and DICER in human CD34+ HSCs.
- HSC function was assessed in vitro and in humanized mouse models.
- mRNA cleavage was analyzed using capture of 5' phosphorylated RNAs.
Main Results:
- DROSHA knockdown, but not DICER knockdown, impaired human HSC differentiation and engraftment.
- DROSHA was confirmed to cleave MYL9 mRNA in human HSCs, leading to its accumulation upon DROSHA deficiency.
- Ectopic MYL9 expression did not affect human HSC function, and a Todr1 homolog was not identified.
Conclusions:
- A miRNA-independent function of DROSHA is essential for human HSC pluripotency.
- DROSHA directly degrades specific mRNAs in human HSCs.
- MYL9 mRNA degradation alone is insufficient to explain DROSHA's role, indicating other targets or functions are critical.
More Related Videos
Related Concept Videos
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Multipotency of Hematopoietic Stem Cells
3.3K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K
Hematopoiesis
5.8K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.8K

